• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Anthem Expands Access to Primary Care in Virginia Through Collaboration with Aledade

Share:

December 4, 2023

Anthem Blue Cross and Blue Shield in Virginia expanded their collaboration with Aledade to enhance primary care accessibility for Virginians. This extended partnership impacts over 80 practices, 15 health centers, and 25 rural clinics, benefitting Medicare Advantage, commercial, and Medicaid members. Aledade focuses on delivering value-based care, notably in underserved areas and community health centers. Positive outcomes include improved diabetes testing rates and increased breast cancer screenings. Shared savings from enhanced care delivery totaled over $2M for Anthem’s commercially-insured patients.

What You Should Know:

– Anthem Blue Cross and Blue Shield in Virginia and Aledade, the nation’s largest network of independent primary care, today announced an expansion of their collaboration to provide more Virginians with access to high-quality primary care.

– The expanded strategic partnership will impact more than 80 practices, 15 health centers, and 25 rural health clinics across Virginia and covers Medicare Advantage, commercially insured, or Medicaid members.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– Aledade is particularly focused on bringing the benefits of value-based care to underserved communities and those receiving care through community health centers (CHCs). The company currently serves as a partner to 15 of Virginia’s 26 CHCs and supports the care of more than 90% of Anthem’s CHC members in Virginia.

Improved Outcomes for Diabetes and Breast Cancer Screening

Anthem and Aledade’s collaboration has already demonstrated positive results. In 2022, primary care practices and CHCs working with the two organizations improved their rates of hemoglobin A1c testing by 10% for patients with diabetes, reaching 9 out of every 10 eligible patients. They also achieved high levels of kidney health evaluation for patients with diabetes. Additionally, practices working with Anthem and Aledade ensured that 3 out of every 4 patients eligible for breast cancer screening received a mammogram.

Shared Savings and Reinvestment in Care Delivery

Shared savings generated through value-based care provide valuable revenue that can be reinvested in care delivery. In Virginia, this high-quality care led to substantial savings among Anthem’s commercially-insured patients, bringing more than $2M in shared savings payments back into community primary care.

“Putting our members and consumers at the center of what we do is our priority through partnerships with innovative companies like Aledade,” said Mark Schneider, Regional Vice President Medicare Market Performance. “Together, we can address the health of people and our healthcare system in the right way, improving health outcomes and lowering costs.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • GE Healthcare Unveils Medical Device Cybersecurity Offering for HospitalsGE Healthcare Unveils Medical Device Cybersecurity Offering for Hospitals
  • Israel Innovation Authority to Invest $31M to Establish R&D Infrastructure Center for Bio-Chips-Based Bio-DevicesIsrael Innovation Authority to Invest $31M to Establish R&D Infrastructure Center for Bio-Chips-Based Bio-Devices
  • Validic Announces High-Frequency Data Support, Delivering Minute-to-Minute Readings From Wearables, Home Health DevicesValidic Announces High-Frequency Data Support, Delivering Minute-to-Minute Readings From Wearables, Home Health Devices
  • Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology PortfolioBristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio
  • After a Tough Summer, X4 Celebrates Phase III Win in WHIM Syndrome (Updated)After a Tough Summer, X4 Celebrates Phase III Win in WHIM Syndrome (Updated)
  • Medical device error messages may tip off hackers on vulnerabilitiesMedical device error messages may tip off hackers on vulnerabilities
  • Digital Health Funding is Off to a Roaring Start in 2020Digital Health Funding is Off to a Roaring Start in 2020
  • Cerner and I2i Population Health Collaborate to Better Serve Medicaid PopulationCerner and I2i Population Health Collaborate to Better Serve Medicaid Population

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications